[Thulium-holmium-chromium-doped YAG laser sclerostomy ab externo in uncontrollable glaucoma].
Identifieur interne : 000C19 ( Ncbi/Checkpoint ); précédent : 000C18; suivant : 000C20[Thulium-holmium-chromium-doped YAG laser sclerostomy ab externo in uncontrollable glaucoma].
Auteurs : T. Hara [Japon] ; M. Adachi ; S. ShiratoSource :
- Nippon Ganka Gakkai zasshi [ 0029-0203 ] ; 1994.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Sclérostomie, Thérapie laser.
- physiopathologie : Glaucome.
- Chrome, Glaucome, Holmium, Humains, Pression intraoculaire, Thulium, Études de suivi.
English descriptors
- KwdEn :
- MESH :
- chemical : Chromium, Holmium, Thulium.
- adverse effects : Laser Therapy, Sclerostomy.
- physiopathology : Glaucoma.
- surgery : Glaucoma.
- Follow-Up Studies, Humans, Intraocular Pressure.
Abstract
Laser sclerostomy ab externo, using thulium-holmium-chromium-doped YAG laser was performed in 40 eyes with refractory glaucoma. Preoperative intraocular pressure (IOP) ranged from 21 to 50 mmHg (mean +/- SD: 33 +/- 18.6) with maximum tolerable medications. In all cases, a full-thickness sclerostomy was performed and subsequently a filtering bleb was formed. Total energy levels to produce the sclerostomy ranged from 0.2 J to 12.9 J (3.9 +/- 2.4). Follow-up periods varied from 3 to 18 (9 +/- 4) months. IOP control rate calculated by a life-table method at 6 and 12 months after surgery was 54% and 46%, respectively. IOP for successful eyes ranged from 0 to 18 mmHg (12.3 +/- 2.4). As complications, corneal fold formation (all eyes), choroidal detachment (12 eyes), hyphema (10 eyes), and iris incarceration in the sclerostomy site (4 eyes) were found. Astigmatism caused by corneal fold formation disappeared spontaneously within 3 months. Iris incarceration causing IOP elevation was repaired by Nd-YAG laser treatment and IOP control was obtained in 2 of 4 eyes. No other complications were observed.
PubMed: 7942342
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000770
- to stream PubMed, to step Curation: 000770
- to stream PubMed, to step Checkpoint: 000770
- to stream Ncbi, to step Merge: 000C19
- to stream Ncbi, to step Curation: 000C19
Links to Exploration step
pubmed:7942342Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Thulium-holmium-chromium-doped YAG laser sclerostomy ab externo in uncontrollable glaucoma].</title><author><name sortKey="Hara, T" sort="Hara, T" uniqKey="Hara T" first="T" last="Hara">T. Hara</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, University of Tokyo School of Medicine, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Ophthalmology, University of Tokyo School of Medicine</wicri:regionArea><wicri:noRegion>University of Tokyo School of Medicine</wicri:noRegion></affiliation></author><author><name sortKey="Adachi, M" sort="Adachi, M" uniqKey="Adachi M" first="M" last="Adachi">M. Adachi</name></author><author><name sortKey="Shirato, S" sort="Shirato, S" uniqKey="Shirato S" first="S" last="Shirato">S. Shirato</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1994">1994</date><idno type="RBID">pubmed:7942342</idno><idno type="pmid">7942342</idno><idno type="wicri:Area/PubMed/Corpus">000770</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000770</idno><idno type="wicri:Area/PubMed/Curation">000770</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000770</idno><idno type="wicri:Area/PubMed/Checkpoint">000770</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000770</idno><idno type="wicri:Area/Ncbi/Merge">000C19</idno><idno type="wicri:Area/Ncbi/Curation">000C19</idno><idno type="wicri:Area/Ncbi/Checkpoint">000C19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Thulium-holmium-chromium-doped YAG laser sclerostomy ab externo in uncontrollable glaucoma].</title><author><name sortKey="Hara, T" sort="Hara, T" uniqKey="Hara T" first="T" last="Hara">T. Hara</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, University of Tokyo School of Medicine, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Ophthalmology, University of Tokyo School of Medicine</wicri:regionArea><wicri:noRegion>University of Tokyo School of Medicine</wicri:noRegion></affiliation></author><author><name sortKey="Adachi, M" sort="Adachi, M" uniqKey="Adachi M" first="M" last="Adachi">M. Adachi</name></author><author><name sortKey="Shirato, S" sort="Shirato, S" uniqKey="Shirato S" first="S" last="Shirato">S. Shirato</name></author></analytic><series><title level="j">Nippon Ganka Gakkai zasshi</title><idno type="ISSN">0029-0203</idno><imprint><date when="1994" type="published">1994</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chromium</term><term>Follow-Up Studies</term><term>Glaucoma (physiopathology)</term><term>Glaucoma (surgery)</term><term>Holmium</term><term>Humans</term><term>Intraocular Pressure</term><term>Laser Therapy (adverse effects)</term><term>Sclerostomy (adverse effects)</term><term>Thulium</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Chrome</term><term>Glaucome ()</term><term>Glaucome (physiopathologie)</term><term>Holmium</term><term>Humains</term><term>Pression intraoculaire</term><term>Sclérostomie (effets indésirables)</term><term>Thulium</term><term>Thérapie laser (effets indésirables)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Chromium</term><term>Holmium</term><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Laser Therapy</term><term>Sclerostomy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Sclérostomie</term><term>Thérapie laser</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Glaucome</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Glaucoma</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Glaucoma</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Follow-Up Studies</term><term>Humans</term><term>Intraocular Pressure</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Chrome</term><term>Glaucome</term><term>Holmium</term><term>Humains</term><term>Pression intraoculaire</term><term>Thulium</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Laser sclerostomy ab externo, using thulium-holmium-chromium-doped YAG laser was performed in 40 eyes with refractory glaucoma. Preoperative intraocular pressure (IOP) ranged from 21 to 50 mmHg (mean +/- SD: 33 +/- 18.6) with maximum tolerable medications. In all cases, a full-thickness sclerostomy was performed and subsequently a filtering bleb was formed. Total energy levels to produce the sclerostomy ranged from 0.2 J to 12.9 J (3.9 +/- 2.4). Follow-up periods varied from 3 to 18 (9 +/- 4) months. IOP control rate calculated by a life-table method at 6 and 12 months after surgery was 54% and 46%, respectively. IOP for successful eyes ranged from 0 to 18 mmHg (12.3 +/- 2.4). As complications, corneal fold formation (all eyes), choroidal detachment (12 eyes), hyphema (10 eyes), and iris incarceration in the sclerostomy site (4 eyes) were found. Astigmatism caused by corneal fold formation disappeared spontaneously within 3 months. Iris incarceration causing IOP elevation was repaired by Nd-YAG laser treatment and IOP control was obtained in 2 of 4 eyes. No other complications were observed.</div></front></TEI><affiliations><list><country><li>Japon</li></country></list><tree><noCountry><name sortKey="Adachi, M" sort="Adachi, M" uniqKey="Adachi M" first="M" last="Adachi">M. Adachi</name><name sortKey="Shirato, S" sort="Shirato, S" uniqKey="Shirato S" first="S" last="Shirato">S. Shirato</name></noCountry><country name="Japon"><noRegion><name sortKey="Hara, T" sort="Hara, T" uniqKey="Hara T" first="T" last="Hara">T. Hara</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000C19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:7942342
|texte= [Thulium-holmium-chromium-doped YAG laser sclerostomy ab externo in uncontrollable glaucoma].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:7942342" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |